▶ 調査レポート

製薬試験・分析サービスの世界市場2020-2030:サービスタイプ別(生物分析試験、方法開発・検証、原材料試験、安定性試験、微生物試験、その他)、エンドユーザー別

• 英文タイトル:Pharmaceutical Testing and Analytical Services Market (Service Type: Bioanalytical Testing, Method Development & Validation, Raw Material Testing, Stability Testing, Microbial Testing, and Others; and End User: Medical Device Companies, Pharmaceutical & Biopharmaceutical Companies, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Transparency Market Researchが調査・発行した産業分析レポートです。製薬試験・分析サービスの世界市場2020-2030:サービスタイプ別(生物分析試験、方法開発・検証、原材料試験、安定性試験、微生物試験、その他)、エンドユーザー別 / Pharmaceutical Testing and Analytical Services Market (Service Type: Bioanalytical Testing, Method Development & Validation, Raw Material Testing, Stability Testing, Microbial Testing, and Others; and End User: Medical Device Companies, Pharmaceutical & Biopharmaceutical Companies, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030 / D0SP201110資料のイメージです。• レポートコード:D0SP201110
• 出版社/出版日:Transparency Market Research / 2020年9月30日
• レポート形態:英文、PDF、195ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥654,835 (USD5,795)▷ お問い合わせ
  Multi User¥993,835 (USD8,795)▷ お問い合わせ
  Corporate License¥1,332,835 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本市場調査レポートでは、製薬試験・分析サービスの世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場動向、サービスタイプ別(生物分析試験、方法開発・検証、原材料試験、安定性試験、微生物試験、その他)分析、エンドユーザー別(医療機器会社、製薬およびバイオ医薬品企業、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの項目を掲載しています。
・序論
・仮定/調査手法
・エグゼクティブサマリー
・市場概要
・市場動向
・製薬試験・分析サービスの世界市場規模:サービスタイプ別(生物分析試験、方法開発・検証、原材料試験、安定性試験、微生物試験、その他)
・製薬試験・分析サービスの世界市場規模:エンドユーザー別(医療機器会社、製薬およびバイオ医薬品企業、その他)
・製薬試験・分析サービスの世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Pharmaceutical Testing and Analytical Services Market – Scope of the Report

TMR’s report on the global pharmaceutical testing and analytical services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global pharmaceutical testing and analytical services market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global pharmaceutical testing and analytical services market from 2020 to 2030.

The report is prepared after an extensive research. Primary research involves bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involved reaching out to key players’ product literature, annual reports, press releases, and relevant documents to understand the pharmaceutical testing and analytical services market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the pharmaceutical testing and analytical services market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global pharmaceutical testing and analytical services market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global pharmaceutical testing and analytical services market.

The report delves into the competition landscape of the global pharmaceutical testing and analytical services market. Key players operating in the global pharmaceutical testing and analytical services market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global pharmaceutical testing and analytical services market profiled in this report.

Key Questions Answered in Pharmaceutical Testing and Analytical Services Market Report

What is the sales/revenue generated by pharmaceutical testing and analytical services across all regions during the forecast period?
What are the opportunities in the global pharmaceutical testing and analytical services market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which service type segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Pharmaceutical Testing and Analytical Services Market – Research Objectives and Research Approach

The comprehensive report on the global pharmaceutical testing and analytical services market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global pharmaceutical testing and analytical services market in terms of service type, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global pharmaceutical testing and analytical services market.

レポート目次

1. Preface

1.1. Report Scope and Market Segmentation

1.2. Research Highlights

2. Assumptions and Research Methodology

2.1. Assumptions and Acronyms Used

2.2. Research Methodology

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Key Industry Developments

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunity

4.4. Global Pharmaceutical Testing and Analytical Services Market Forecast

4.5. Global Pharmaceutical Testing and Analytical Services Market Outlook

5. Market Outlook

5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)

5.2. Clinical Trials Analysis

5.3. Covid-19 Impact Analysis

6. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Service Type

6.1. Introduction

6.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

6.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

6.3.1. Bioanalytical Testing

6.3.1.1. Cell-Based Assays

6.3.1.2. Virology Testing

6.3.1.3. Others

6.3.2. Method Development & Validation

6.3.2.1. Extractables & Leachables Method Development & Validation

6.3.2.2. Stability-indicating Method Validation

6.3.2.3. Process Impurity Method Development & Validation

6.3.2.4. Others

6.3.3. Raw Material Testing

6.3.3.1. Heavy Metal Testing

6.3.3.2. Complete Compendial Testing

6.3.3.3. Others

6.3.4. Stability Testing

6.3.4.1. Drug Substance Stability Testing

6.3.4.2. Formulation Evaluation Stability Testing

6.3.4.3. Others

6.3.5. Microbial Testing

6.3.5.1. Microbial Limit Testing

6.3.5.2. Sterility Testing

6.3.5.3. Endotoxin Testing

6.3.5.4. Others

6.3.6. Others

6.4. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Service Type

7. Global Pharmaceutical Testing and Analytical Services Market Analysis, by End-user

7.1. Introduction

7.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

7.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

7.3.1. Medical Device Companies

7.3.2. Pharmaceutical & Biopharmaceutical Companies

7.3.3. Others

7.4. Global Pharmaceutical Testing and Analytical Services Market Analysis, by End-user

8. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Region

8.1. Global Pharmaceutical Testing and Analytical Services Market Scenario, by Region

8.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Region

8.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by Region

8.3.1. North America

8.3.2. Europe

8.3.3. Asia Pacific

8.3.4. Latin America

8.3.5. Middle East & Africa

9. North America Pharmaceutical Testing and Analytical Services Market Analysis

9.1. North America Pharmaceutical Testing and Analytical Services Market Overview

9.2. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country

9.3. North America Pharmaceutical Testing and Analytical Services Market Forecast, by Country

9.3.1. U.S.

9.3.2. Canada

9.4. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

9.5. North America Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

9.5.1. Bioanalytical Testing

9.5.1.1. Cell-Based Assays

9.5.1.2. Virology Testing

9.5.1.3. Others

9.5.2. Method Development & Validation

9.5.2.1. Extractables & Leachables Method Development & Validation

9.5.2.2. Stability-indicating Method Validation

9.5.2.3. Process Impurity Method Development & Validation

9.5.2.4. Others

9.5.3. Raw Material Testing

9.5.3.1. Heavy Metal Testing

9.5.3.2. Complete Compendial Testing

9.5.3.3. Others

9.5.4. Stability Testing

9.5.4.1. Drug Substance Stability Testing

9.5.4.2. Formulation Evaluation Stability Testing

9.5.4.3. Others

9.5.5. Microbial Testing

9.5.5.1. Microbial Limit Testing

9.5.5.2. Sterility Testing

9.5.5.3. Endotoxin Testing

9.5.5.4. Others

9.5.6. Others

9.6. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

9.7. North America Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

9.7.1. Medical Devices Companies

9.7.2. Pharmaceutical & Biopharmaceutical Companies

9.7.3. Others

10. Europe Pharmaceutical Testing and Analytical Services Market Analysis

10.1. Europe Pharmaceutical Testing and Analytical Services Market Overview

10.2. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region

10.3. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region

10.3.1. Germany

10.3.2. France

10.3.3. U.K.

10.3.4. Italy

10.3.5. Spain

10.3.6. Rest of Europe

10.4. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

10.5. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

10.5.1. Bioanalytical Testing

10.5.1.1. Cell-Based Assays

10.5.1.2. Virology Testing

10.5.1.3. Others

10.5.2. Method Development & Validation

10.5.2.1. Extractables & Leachables Method Development & Validation

10.5.2.2. Stability-indicating Method Validation

10.5.2.3. Process Impurity Method Development & Validation

10.5.2.4. Others

10.5.3. Raw Material Testing

10.5.3.1. Heavy Metal Testing

10.5.3.2. Complete Compendial Testing

10.5.3.3. Others

10.5.4. Stability Testing

10.5.4.1. Drug Substance Stability Testing

10.5.4.2. Formulation Evaluation Stability Testing

10.5.4.3. Others

10.5.5. Microbial Testing

10.5.5.1. Microbial Limit Testing

10.5.5.2. Sterility Testing

10.5.5.3. Endotoxin Testing

10.5.5.4. Others

10.5.6. Others

10.6. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

10.7. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

10.7.1. Medical Devices Companies

10.7.2. Pharmaceutical & Biopharmaceutical Companies

10.7.3. Others

11. Asia Pacific Pharmaceutical Testing and Analytical Services Market Analysis

11.1. Asia Pacific Pharmaceutical Testing and Analytical Services Market Overview

11.2. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region

11.3. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region

11.3.1. Japan

11.3.2. China

11.3.3. India

11.3.4. Australia & New Zealand

11.3.5. Rest of Asia Pacific

11.4. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

11.5. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

11.5.1. Bioanalytical Testing

11.5.1.1. Cell-Based Assays

11.5.1.2. Virology Testing

11.5.1.3. Others

11.5.2. Method Development & Validation

11.5.2.1. Extractables & Leachables Method Development & Validation

11.5.2.2. Stability-indicating Method Validation

11.5.2.3. Process Impurity Method Development & Validation

11.5.2.4. Others

11.5.3. Raw Material Testing

11.5.3.1. Heavy Metal Testing

11.5.3.2. Complete Compendial Testing

11.5.3.3. Others

11.5.4. Stability Testing

11.5.4.1. Drug Substance Stability Testing

11.5.4.2. Formulation Evaluation Stability Testing

11.5.4.3. Others

11.5.5. Microbial Testing

11.5.5.1. Microbial Limit Testing

11.5.5.2. Sterility Testing

11.5.5.3. Endotoxin Testing

11.5.5.4. Others

11.5.6. Others

11.6. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

11.7. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

11.7.1. Medical Devices Companies

11.7.2. Pharmaceutical & Biopharmaceutical Companies

11.7.3. Others

12. Latin America Pharmaceutical Testing and Analytical Services Market Analysis

12.1. Latin America Pharmaceutical Testing and Analytical Services Market Overview

12.2. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region

12.3. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region

12.3.1. Brazil

12.3.2. Mexico

12.3.3. Rest of Latin America

12.4. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

12.5. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

12.5.1. Bioanalytical Testing

12.5.1.1. Cell-Based Assays

12.5.1.2. Virology Testing

12.5.1.3. Others

12.5.2. Method Development & Validation

12.5.2.1. Extractables & Leachables Method Development & Validation

12.5.2.2. Stability-indicating Method Validation

12.5.2.3. Process Impurity Method Development & Validation

12.5.2.4. Others

12.5.3. Raw Material Testing

12.5.3.1. Heavy Metal Testing

12.5.3.2. Complete Compendial Testing

12.5.3.3. Others

12.5.4. Stability Testing

12.5.4.1. Drug Substance Stability Testing

12.5.4.2. Formulation Evaluation Stability Testing

12.5.4.3. Others

12.5.5. Microbial Testing

12.5.5.1. Microbial Limit Testing

12.5.5.2. Sterility Testing

12.5.5.3. Endotoxin Testing

12.5.5.4. Others

12.5.6. Others

12.6. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

12.7. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

12.7.1. Medical Devices Companies

12.7.2. Pharmaceutical & Biopharmaceutical Companies

12.7.3. Others

13. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Analysis

13.1. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Overview

13.2. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region

13.3. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region

13.3.1. GCC Countries

13.3.2. South Africa

13.3.3. Rest of Middle East & Africa

13.4. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type

13.5. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type

13.5.1. Bioanalytical Testing

13.5.1.1. Cell-Based Assays

13.5.1.2. Virology Testing

13.5.1.3. Others

13.5.2. Method Development & Validation

13.5.2.1. Extractables & Leachables Method Development & Validation

13.5.2.2. Stability-indicating Method Validation

13.5.2.3. Process Impurity Method Development & Validation

13.5.2.4. Others

13.5.3. Raw Material Testing

13.5.3.1. Heavy Metal Testing

13.5.3.2. Complete Compendial Testing

13.5.3.3. Others

13.5.4. Stability Testing

13.5.4.1. Drug Substance Stability Testing

13.5.4.2. Formulation Evaluation Stability Testing

13.5.4.3. Others

13.5.5. Microbial Testing

13.5.5.1. Microbial Limit Testing

13.5.5.2. Sterility Testing

13.5.5.3. Endotoxin Testing

13.5.5.4. Others

13.5.6. Others

13.6. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user

13.7. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by End-user

13.7.1. Medical Devices Companies

13.7.2. Pharmaceutical & Biopharmaceutical Companies

13.7.3. Others

14. Competitive Landscape

14.1. Competition Matrix

14.2. Global Pharmaceutical Testing and Analytical Services Market Share Analysis, by Company

14.3. Company Profile

14.3.1. Eurofins Scientific

14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.1.2. Financial Overview

14.3.1.3. Product Portfolio

14.3.1.4. SWOT Analysis

14.3.1.5. Strategic Overview

14.3.2. Laboratory Corporation of America Holdings

14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.2.2. Financial Overview

14.3.2.3. Product Portfolio

14.3.2.4. SWOT Analysis

14.3.2.5. Strategic Overview

14.3.3. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.3.2. Financial Overview

14.3.3.3. Product Portfolio

14.3.3.4. SWOT Analysis

14.3.3.5. Strategic Overview

14.3.4. SGS S.A

14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.4.2. Product Portfolio

14.3.4.3. SWOT Analysis

14.3.4.4. Strategic Overview

14.3.5. Intertek Group plc

14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.5.2. Financial Overview

14.3.5.3. Product Portfolio

14.3.5.4. SWOT Analysis

14.3.5.5. Strategic Overview

14.3.6. RD Laboratories, Inc

14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.6.2. Financial Overview

14.3.6.3. Product Portfolio

14.3.6.4. SWOT Analysis

14.3.6.5. Strategic Overview

14.3.7. WuXi AppTec Co., Ltd.

14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.7.2. Financial Overview

14.3.7.3. Product Portfolio

14.3.7.4. SWOT Analysis

14.3.7.5. Strategic Overview

14.3.8. DYNALABS LLC (Infinity Laboratories)

14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.8.2. Financial Overview

14.3.8.3. Product Portfolio

14.3.8.4. SWOT Analysis

14.3.8.5. Strategic Overview

14.3.9. ARL Bio Pharma

14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.9.2. Financial Overview

14.3.9.3. Product Portfolio

14.3.9.4. SWOT Analysis

14.3.9.5. Strategic Overview

Purchase Options

Single User License $5795
Multi-User License $8795
Corporate License $11795
Buy Now
Related Reports

Genetic Disease Diagnostic Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024
Drug Adherence Enhancement Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 – 2027
Curved Tip Serrated Forceps Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025
Medical Grade Gels Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027
Breastfeeding Accessories Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027
Plate Sealer Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026
Dental Mirror Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026
Stool Management Systems Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 – 2027
Contralateral Routing of Signals Hearing Aid Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 – 2026
Carbohydrase Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024
Audiology Services Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2020 – 2030
Neurology Endoscopy Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025
Mucosal Atomization Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027
Dural Sealants Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014- 2020
Special Purpose Needles Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2027
Custom Market Resear

List of Tables

Table 01: Epidemiology of COVID-19 Country/Sub-region

Table 02: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 03: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030

Table 04: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030

Table 05: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030

Table 06: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030

Table 07: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030

Table 08: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 09: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 10: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 11: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 12: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030

Table 13: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030

Table 14: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030

Table 15: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030

Table 16: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030

Table 17: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 18: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 19: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 20: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030

Table 21: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030

Table 22: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030

Table 23: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030

Table 24: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030

Table 25: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 26: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030

Table 27: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 28: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030

Table 29: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030

Table 30: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030

Table 31: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030

Table 32: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030

Table 33: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 34: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030

Table 35: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 36: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030

Table 37: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030

Table 38: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030

Table 39: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030

Table 40: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030

Table 41: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 42: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030

Table 43: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030

Table 44: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030

Table 45: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030

Table 46: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030

Table 47: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030

Table 48: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030

Table 49: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030